Kenneth Olden

Kenneth Olden Director, National Institute of Environmental Health Sciences and National Toxicology Program, Research Triangle Park, N.C. "THE SCIENTIST is an excellent way to keep up with what's going on in science, with balanced coverage of programs, developments, and what the movers and shakers are thinking." The National Institute of Environmental Health Sciences is dedicated to discovering how environmental agents disrupt biological processes and using this knowledge to prevent disease.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Kenneth Olden
Director, National Institute of Environmental Health Sciences and National Toxicology Program, Research Triangle Park, N.C.

"THE SCIENTIST is an excellent way to keep up with what's going on in science, with balanced coverage of programs, developments, and what the movers and shakers are thinking."

The National Institute of Environmental Health Sciences is dedicated to discovering how environmental agents disrupt biological processes and using this knowledge to prevent disease. With Kenneth Olden as director, NIEHS has attracted national and international attention for research contributions on health issues including cancer and birth defects, as well as Alzheimer's disease and asthma.

An expert in tumor biology, Olden was the first to demonstrate that organ-specific metastasis of malignant cells can be prevented by blocking the interaction between fibronectin and the integrin receptor. As a result of his accomplishments, Olden has been elected to the Institute of Medicine of the National Academy of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies